+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Hospital Acquired Infection Control Market by Type (Diagnostic & Testing Equipment, Disinfection Products, Hand Hygiene Products), Indication (Bloodstream Infections, Clostridioides difficile Infections, Hospital-acquired Pneumonia), End-user - Forecast 2024-2030

  • PDF Icon

    Report

  • 181 Pages
  • June 2024
  • Region: Global
  • 360iResearch™
  • ID: 5454889
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Hospital Acquired Infection Control Market grew from USD 34.26 billion in 2023 to USD 36.39 billion in 2024. It is expected to continue growing at a CAGR of 6.48%, reaching USD 53.20 billion by 2030.

These infections can occur as a result of exposure to various microbial agents, including bacteria, viruses, fungi, and other pathogens. The control measures span a wide range of strategies, including rigorous hygiene practices, sterilization and disinfection procedures, use of personal protective equipment (PPE), surveillance of infections, and adherence to protocols for invasive procedures and antibiotic stewardship. The rising awareness about infections acquired in healthcare settings, coupled with a rapidly growing emphasis on infection control policies, boosts the market growth. However, high costs associated with advanced infection control technologies can be prohibitive for resource-limited settings. Furthermore, technological advancements in sterilization and disinfection processes, along with the development of eco-friendly and more efficient disinfectants, pose significant opportunities to the manufacturers.

Regional Insights

The Americas, led by the United States and Canada, exhibit a robust demand for HAI control solutions, attributed to stringent regulatory standards and a high level of healthcare expenditure. Innovation and technological advancement are key factors, with a focus on non-toxic, eco-friendly disinfection methods and smart monitoring systems. In the European Union, stringent regulations and a focus on accreditation and quality in healthcare drive the demand for high-standard HAI control solutions. EU-wide initiatives aim at harmonizing infection control practices, enhancing cross-border cooperation in HAI research, and fostering innovation. The Middle East is witnessing a healthcare transformation, with significant investments in hospital infrastructure and quality improvement initiatives. There is an increasing demand for advanced infection control technologies, albeit with a preference for cost-effective solutions in some countries. The Asia Pacific region is noted for its rapid adoption of advanced HAI control solutions, driven by growing healthcare infrastructure and heightened awareness of infection-prevention protocols. China and Japan are prominent countries in APAC with substantial investments in R&D, while India is emerging as a substantial market due to its increasing number of hospitals and focus on healthcare quality. Customer purchasing behavior in this region leans towards integrated solutions offering both cost efficiency and effectiveness.

Market Insights

Market Dynamics

  • The market dynamics represent an ever-changing landscape of the Hospital Acquired Infection Control Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

  • Rising awareness about infections in healthcare settings with growing emphasis on infection control policies
  • Growing prevalence of chronic diseases with increasing geriatric population
  • Increasing use of disinfectants and medical nonwovens in the healthcare industry

Market Restraints

  • High cost associated with the endoscope reprocessors and microbial testing instruments

Market Opportunities

  • Increasing investments in R&D coupled with high usage of consumables in hospitals
  • Technological advancements in sterilization & disinfection processes and infection control devices

Market Challenges

  • Concerns associated with the safety of reprocessed instruments

Market Segmentation Analysis

  • Type: Ongoing technological advancements in diagnostic and testing equipment to increase efficiency
  • End-user: Hospitals & ICUs emphasize comprehensive and automated solutions for high-risk environments

Industry Insights

  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Hospital Acquired Infection Control Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Hospital Acquired Infection Control Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Ahlstrom launches Reliance Fusion next-generation simultaneous sterilization wrap

Ahlstrom introduces its innovation for the medical industry, Reliance Fusion, a groundbreaking sterilization wrap engineered to enhance the efficiency of surgical instrument sterilization in hospitals. Combining the best features of both cellulose-based and polypropylene materials through advanced wet-laid technology and SMS (Spunbond-Meltblown-Spunbond), this novel solution significantly reduces drying times, minimizes the risk of wet packs and improves overall throughput in hospitals' Central Sterilization Service Departments (CSSD).

PAMA introduces new ethylene oxide sterilisation solution

PAMA Manufacturing and Sterilization has unveiled its latest advance in medical equipment sterilization. An innovative ethylene oxide (EO) sterilization process that sets new standards in eco-efficiency, cost-effectiveness, and safety without compromising on sterilization efficacy. This initiative addresses growing concerns surrounding EO emissions and their health implications for individuals in and around sterilization facilities and reinforces PAMA’s commitment to ensuring the consistent supply of sterile, high-quality medical devices vital for healthcare.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Hospital Acquired Infection Control Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Hospital Acquired Infection Control Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Abbott Laboratories, Advanced Sterilization Products Services Inc., AHLSTROM OYJ, Becton, Dickinson and Company, Belimed AG, Cantel Medical Corporation by STERIS PLC, Cardinal Health, Inc., DNV AS, Ecolab Inc., F. Hoffmann-La Roche Ltd, GOJO Industries, Inc., Henkel AG & Co. KGaA, Kimberly-Clark Corporation, Medline Industries, LP, Olympus Corporation, Sterigenics International LLC, and Unilever PLC.

Market Segmentation & Coverage

This research report categorizes the Hospital Acquired Infection Control Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type

  • Diagnostic & Testing Equipment
  • Disinfection Products
  • Hand Hygiene Products
  • Personal Protective Equipment
  • Sterilization Equipment

Indication

  • Bloodstream Infections
  • Clostridioides difficile Infections
  • Hospital-acquired Pneumonia
  • Multidrug-Resistant Organisms
  • Surgical Site Infections
  • Urinary Tract Infections

End-user

  • Ambulatory Surgical & Diagnostic Centers
  • Hospitals & ICUs
  • Nursing Homes & Maternity Centers

Region

Americas

  • Argentina
  • Brazil
  • Canada
  • Mexico
  • United States
  • California
  • Florida
  • Illinois
  • New York
  • Ohio
  • Pennsylvania
  • Texas

Asia-Pacific

  • Australia
  • China
  • India
  • Indonesia
  • Japan
  • Malaysia
  • Philippines
  • Singapore
  • South Korea
  • Taiwan
  • Thailand
  • Vietnam

Europe, Middle East & Africa

  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

Additional Product Information:

  • The purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
  • With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase
  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Additional Product Information:

  • The purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
  • With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase
  • Purchase of this report includes 1 year online access with quarterly updates
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising awareness about infections in healthcare settings with growing emphasis on infection control policies
5.1.1.2. Growing prevalence of chronic diseases with increasing geriatric population
5.1.1.3. Increasing use of disinfectants and medical nonwovens in the healthcare industry
5.1.2. Restraints
5.1.2.1. High cost associated with the endoscope reprocessors and microbial testing instruments
5.1.3. Opportunities
5.1.3.1. Increasing investments in R&D coupled with high usage of consumables in hospitals
5.1.3.2. Technological advancements in sterilization & disinfection processes and infection control devices
5.1.4. Challenges
5.1.4.1. Concerns associated with the safety of reprocessed instruments
5.2. Market Segmentation Analysis
5.2.1. Type: Ongoing technological advancements in diagnostic and testing equipment to increase efficiency
5.2.2. End-user: Hospitals & ICUs emphasize comprehensive and automated solutions for high-risk environments
5.3. Market Disruption Analysis
5.4. Porter’s Five Forces Analysis
5.4.1. Threat of New Entrants
5.4.2. Threat of Substitutes
5.4.3. Bargaining Power of Customers
5.4.4. Bargaining Power of Suppliers
5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis
6. Hospital Acquired Infection Control Market, by Type
6.1. Introduction
6.2. Diagnostic & Testing Equipment
6.3. Disinfection Products
6.4. Hand Hygiene Products
6.5. Personal Protective Equipment
6.6. Sterilization Equipment
7. Hospital Acquired Infection Control Market, by Indication
7.1. Introduction
7.2. Bloodstream Infections
7.3. Clostridioides difficile Infections
7.4. Hospital-acquired Pneumonia
7.5. Multidrug-Resistant Organisms
7.6. Surgical Site Infections
7.7. Urinary Tract Infections
8. Hospital Acquired Infection Control Market, by End-user
8.1. Introduction
8.2. Ambulatory Surgical & Diagnostic Centers
8.3. Hospitals & ICUs
8.4. Nursing Homes & Maternity Centers
9. Americas Hospital Acquired Infection Control Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Hospital Acquired Infection Control Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Hospital Acquired Infection Control Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
12.3.1. Ahlstrom launches Reliance Fusion next-generation simultaneous sterilization wrap
12.3.2. PAMA introduces new ethylene oxide sterilisation solution
12.4. Strategy Analysis & Recommendation
13. Competitive Portfolio
13.1. Key Company Profiles
13.2. Key Product Portfolio
List of Figures
FIGURE 1. HOSPITAL ACQUIRED INFECTION CONTROL MARKET RESEARCH PROCESS
FIGURE 2. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. HOSPITAL ACQUIRED INFECTION CONTROL MARKET DYNAMICS
FIGURE 7. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
FIGURE 8. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
FIGURE 10. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 12. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 22. HOSPITAL ACQUIRED INFECTION CONTROL MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DIAGNOSTIC & TESTING EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DIAGNOSTIC & TESTING EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DISINFECTION PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY DISINFECTION PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HAND HYGIENE PRODUCTS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HAND HYGIENE PRODUCTS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY PERSONAL PROTECTIVE EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STERILIZATION EQUIPMENT, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY BLOODSTREAM INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY CLOSTRIDIOIDES DIFFICILE INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY CLOSTRIDIOIDES DIFFICILE INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITAL-ACQUIRED PNEUMONIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITAL-ACQUIRED PNEUMONIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY MULTIDRUG-RESISTANT ORGANISMS, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY MULTIDRUG-RESISTANT ORGANISMS, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY SURGICAL SITE INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY SURGICAL SITE INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY AMBULATORY SURGICAL & DIAGNOSTIC CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY AMBULATORY SURGICAL & DIAGNOSTIC CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITALS & ICUS, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY HOSPITALS & ICUS, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY NURSING HOMES & MATERNITY CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY NURSING HOMES & MATERNITY CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 41. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 42. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 43. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 44. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 45. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 46. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 47. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 48. AMERICAS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 49. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 50. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 51. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 52. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 53. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 54. ARGENTINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 55. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 56. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 57. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 58. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 59. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 60. BRAZIL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 61. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 62. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 63. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 64. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 65. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 66. CANADA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 67. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 68. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 69. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 70. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 71. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 72. MEXICO HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 73. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 74. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 75. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 76. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 77. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 78. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 79. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 80. UNITED STATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 81. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 82. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 83. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 84. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 85. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 86. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 87. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 88. ASIA-PACIFIC HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 89. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 90. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 91. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 92. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 93. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 94. AUSTRALIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 95. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 96. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 97. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 98. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 99. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 100. CHINA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 101. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 102. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 103. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 104. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 105. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 106. INDIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 107. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 108. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 109. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 110. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 111. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 112. INDONESIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 113. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 114. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 115. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 116. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 117. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 118. JAPAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 119. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 120. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 121. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 122. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 123. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 124. MALAYSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 125. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 126. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 127. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 128. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 129. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 130. PHILIPPINES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 131. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 132. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 133. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 134. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 135. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 136. SINGAPORE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 137. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 138. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 139. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 140. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 141. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 142. SOUTH KOREA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 143. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 144. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 145. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 146. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 147. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 148. TAIWAN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 149. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 150. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 151. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 152. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 153. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 154. THAILAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 155. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 156. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 157. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 158. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 159. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 160. VIETNAM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 169. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 170. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 171. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 172. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 173. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 174. DENMARK HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 175. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 176. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 177. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 178. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 179. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 180. EGYPT HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 181. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 182. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 183. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 184. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 185. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 186. FINLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 187. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 188. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 189. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 190. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 191. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 192. FRANCE HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 193. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 194. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 195. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 196. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 197. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 198. GERMANY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 199. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 200. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 201. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 202. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 203. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 204. ISRAEL HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 205. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 206. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 207. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 208. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 209. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 210. ITALY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 211. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 212. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 213. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 214. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 215. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 216. NETHERLANDS HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 217. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 218. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 219. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 220. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 221. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 222. NIGERIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 223. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 224. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 225. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 226. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 227. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 228. NORWAY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 229. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 230. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 231. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 232. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 233. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 234. POLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 235. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 236. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 237. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 238. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 239. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 240. QATAR HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 241. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 242. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 243. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 244. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 245. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 246. RUSSIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 247. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 248. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 249. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 250. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 251. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 252. SAUDI ARABIA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 253. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 254. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 255. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 256. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 257. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 258. SOUTH AFRICA HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 259. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 260. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 261. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 262. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 263. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 264. SPAIN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 265. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 266. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 267. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 268. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 269. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 270. SWEDEN HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 271. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 272. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 273. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 274. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 275. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 276. SWITZERLAND HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 277. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 278. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 279. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 280. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 281. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 282. TURKEY HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 283. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 284. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 285. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 286. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 287. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 288. UNITED ARAB EMIRATES HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 289. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2018-2023 (USD MILLION)
TABLE 290. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY TYPE, 2024-2030 (USD MILLION)
TABLE 291. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
TABLE 292. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
TABLE 293. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 294. UNITED KINGDOM HOSPITAL ACQUIRED INFECTION CONTROL MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 295. HOSPITAL ACQUIRED INFECTION CONTROL MARKET SHARE, BY KEY PLAYER, 2023
TABLE 296. HOSPITAL ACQUIRED INFECTION CONTROL MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

  • 3M Company
  • Abbott Laboratories
  • Advanced Sterilization Products Services Inc.
  • AHLSTROM OYJ
  • Becton, Dickinson and Company
  • Belimed AG
  • Cantel Medical Corporation by STERIS PLC
  • Cardinal Health, Inc.
  • DNV AS
  • Ecolab Inc.
  • F. Hoffmann-La Roche Ltd
  • GOJO Industries, Inc.
  • Henkel AG & Co. KGaA
  • Kimberly-Clark Corporation
  • Medline Industries, LP
  • Olympus Corporation
  • Sterigenics International LLC
  • Unilever PLC

Methodology

Loading
LOADING...

Table Information